Clearside Biomedical Inc (CLSD)
1.30
+0.04
(+3.17%)
USD |
NASDAQ |
May 02, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Net Income (Quarterly): -4.832M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.832M |
September 30, 2023 | -9.267M |
June 30, 2023 | -9.106M |
March 31, 2023 | -9.28M |
December 31, 2022 | -9.663M |
September 30, 2022 | -7.827M |
June 30, 2022 | -7.813M |
March 31, 2022 | -7.644M |
December 31, 2021 | 18.71M |
September 30, 2021 | -4.887M |
June 30, 2021 | -6.095M |
March 31, 2021 | -7.351M |
December 31, 2020 | -7.112M |
September 30, 2020 | -2.433M |
June 30, 2020 | -5.754M |
March 31, 2020 | -2.911M |
December 31, 2019 | -3.096M |
September 30, 2019 | -6.536M |
June 30, 2019 | -5.734M |
Date | Value |
---|---|
March 31, 2019 | -15.40M |
December 31, 2018 | -21.64M |
September 30, 2018 | -23.87M |
June 30, 2018 | -20.70M |
March 31, 2018 | -16.61M |
December 31, 2017 | -16.49M |
September 30, 2017 | -18.34M |
June 30, 2017 | -13.77M |
March 31, 2017 | -10.37M |
December 31, 2016 | -9.686M |
September 30, 2016 | -5.645M |
June 30, 2016 | -5.102M |
March 31, 2016 | -5.449M |
December 31, 2015 | -5.17M |
September 30, 2015 | -3.475M |
June 30, 2015 | -5.237M |
March 31, 2015 | -3.757M |
December 31, 2014 | -2.663M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.663M
Minimum
Dec 2022
18.71M
Maximum
Dec 2021
-5.191M
Average
-6.536M
Median
Sep 2019
Net Income (Quarterly) Benchmarks
Cassava Sciences Inc | -20.92M |
Heron Therapeutics Inc | -10.72M |
Actinium Pharmaceuticals Inc | -8.67M |
Karyopharm Therapeutics Inc | -41.84M |
Ocular Therapeutix Inc | -29.22M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 6.345M |
Total Expenses (Quarterly) | 9.26M |
EPS Diluted (Quarterly) | -0.08 |
Enterprise Value | 65.23M |
Profit Margin (Quarterly) | -76.15% |
Earnings Yield | -40.77% |
Normalized Earnings Yield | -40.77 |